CUE logo

Cue Biopharma (CUE) Cash From Operations

Annual CFO

-$39.96 M
+$1.84 M+4.41%

December 31, 2023

Summary

Performance

1-Year Change

+4.41%

3-Year Change

-22.98%

5-Year Change

-51.3%

15-Year Change

-229.13%

CUE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.14%
CUE annual cash flow from operations is higher than 32.14% of companies in Healthcare sector

High & Low

All-time High

-$1.66 M

3-Year Low

-$41.81 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CUE previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 8, 2025
CUE next annual earnings announcement is scheduled for Apr 8, 2025

OtherCUEcash flowmetrics:

Annual CFI

$25.00 M
CUE annual cash flow from investing activities is $25.00 million

Annual CFF

$11.86 M
CUE annual cash flow from financing activities is $11.86 million

Annual FCF

-$39.96 M
CUE annual free cash flow is -$39.96 million

Annual CAPEX

-
CUE annual capital expenditures value is unknown

Quarterly CFO

-$7.53 M
+$2.46 M+24.65%

September 30, 2024

Summary

Performance

3-Month Change

+24.65%

1-Year Change

+24.65%

3-Year Change

+28.41%

5-Year Change

+28.41%

CUE Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

37.5%
CUE quarterly cash flow from operations is higher than 37.5% of companies in Healthcare sector

High & Low

All-time High

-$1.85 M

3-Year Low

-$12.85 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CUE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
CUE next earnings announcement is scheduled for Apr 8, 2025

OtherCUEcash flowmetrics:

Quarterly CFI

$98.00 K
CUE quarterly cash flow from investing activities is $98.00 thousand

Quarterly CFF

$9.82 M
CUE quarterly cash flow from financing activities is $9.82 million

Quarterly FCF

-$7.53 M
CUE quarterly free cash flow is -$7.53 million

Quarterly CAPEX

-$1000.00
CUE quarterly capital expenditures is -$1000.00

TTM CFO

-$38.26 M
+$272.00 K+0.71%

September 30, 2024

Summary

Performance

3-Month Change

+0.71%

1-Year Change

+0.71%

3-Year Change

+8.48%

5-Year Change

+8.48%

CUE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.01%
CUE TTM cash flow from operations is higher than 33.01% of companies in Healthcare sector

High & Low

All-time High

-$3.46 M

3-Year Low

-$41.94 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CUE previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
CUE next earnings announcement is scheduled for Apr 8, 2025

OtherCUEcash flowmetrics:

TTM CFI

$33.00 K
CUE TTM cash flow from investing activities is $33.00 thousand

TTM CFF

$15.96 M
CUE TTM cash flow from financing activities is $15.96 million

TTM FCF

-$38.32 M
CUE TTM free cash flow is -$38.32 million

TTM CAPEX

$64.00 K
CUE TTM capital expenditures is $64.00 thousand

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CUE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.4%+24.6%+0.7%
3 y3 years-23.0%+28.4%+8.5%
5 y5 years-51.3%+28.4%+8.5%

CUE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2.9%+4.4%-9.6%+41.4%at high+8.8%
5 y5-year-29.8%+4.4%-16.9%+41.4%-24.2%+8.8%
alltimeall time-2310.8%+4.4%-307.9%+41.4%-1004.5%+8.8%

Cue Biopharma Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$7.53 M(-24.7%)
-$38.26 M(-0.7%)
Jun 2024
-
-$9.99 M(+2.1%)
-$38.53 M(-1.0%)
Mar 2024
-
-$9.78 M(-10.7%)
-$38.91 M(-2.6%)
Dec 2023
-$39.96 M(-4.4%)
-$10.96 M(+40.5%)
-$39.96 M(+1.1%)
Sep 2023
-
-$7.80 M(-24.8%)
-$39.52 M(+2.4%)
Jun 2023
-
-$10.37 M(-4.3%)
-$38.59 M(-6.0%)
Mar 2023
-
-$10.83 M(+3.0%)
-$41.07 M(-1.8%)
Dec 2022
-$41.81 M(+7.6%)
-$10.51 M(+53.0%)
-$41.81 M(-0.3%)
Sep 2022
-
-$6.87 M(-46.5%)
-$41.94 M(+0.6%)
Jun 2022
-
-$12.85 M(+11.0%)
-$41.69 M(+8.0%)
Mar 2022
-
-$11.57 M(+8.7%)
-$38.62 M(-0.6%)
Dec 2021
-$38.84 M(+19.5%)
-$10.65 M(+60.6%)
-$38.84 M(+10.4%)
Sep 2021
-
-$6.63 M(-32.2%)
-$35.19 M(-2.9%)
Jun 2021
-
-$9.77 M(-17.2%)
-$36.25 M(+8.7%)
Mar 2021
-
-$11.79 M(+68.5%)
-$33.34 M(+2.6%)
Dec 2020
-$32.49 M
-$7.00 M(-9.0%)
-$32.49 M(+1.8%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$7.69 M(+12.0%)
-$31.93 M(-4.5%)
Jun 2020
-
-$6.86 M(-37.3%)
-$33.45 M(+0.6%)
Mar 2020
-
-$10.94 M(+70.0%)
-$33.27 M(+8.0%)
Dec 2019
-$30.80 M(+16.6%)
-$6.44 M(-30.1%)
-$30.80 M(+9.0%)
Sep 2019
-
-$9.21 M(+37.9%)
-$28.26 M(+11.5%)
Jun 2019
-
-$6.68 M(-21.2%)
-$25.35 M(+0.9%)
Mar 2019
-
-$8.47 M(+117.4%)
-$25.13 M(-4.9%)
Dec 2018
-$26.41 M(+117.5%)
-$3.90 M(-38.1%)
-$26.41 M(+8.4%)
Sep 2018
-
-$6.30 M(-2.4%)
-$24.36 M(+12.1%)
Jun 2018
-
-$6.46 M(-33.8%)
-$21.74 M(+17.9%)
Mar 2018
-
-$9.76 M(+428.8%)
-$18.44 M(+51.8%)
Dec 2017
-$12.14 M(+103.4%)
-$1.85 M(-49.8%)
-$12.14 M(+17.9%)
Sep 2017
-
-$3.68 M(+16.5%)
-$10.30 M(+55.5%)
Jun 2017
-
-$3.16 M(-8.9%)
-$6.62 M(+91.1%)
Mar 2017
-
-$3.46 M
-$3.46 M
Dec 2016
-$5.97 M(+260.1%)
-
-
Dec 2015
-$1.66 M
-
-

FAQ

  • What is Cue Biopharma annual cash flow from operations?
  • What is the all time high annual CFO for Cue Biopharma?
  • What is Cue Biopharma annual CFO year-on-year change?
  • What is Cue Biopharma quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Cue Biopharma?
  • What is Cue Biopharma quarterly CFO year-on-year change?
  • What is Cue Biopharma TTM cash flow from operations?
  • What is the all time high TTM CFO for Cue Biopharma?
  • What is Cue Biopharma TTM CFO year-on-year change?

What is Cue Biopharma annual cash flow from operations?

The current annual CFO of CUE is -$39.96 M

What is the all time high annual CFO for Cue Biopharma?

Cue Biopharma all-time high annual cash flow from operations is -$1.66 M

What is Cue Biopharma annual CFO year-on-year change?

Over the past year, CUE annual cash flow from operations has changed by +$1.84 M (+4.41%)

What is Cue Biopharma quarterly cash flow from operations?

The current quarterly CFO of CUE is -$7.53 M

What is the all time high quarterly CFO for Cue Biopharma?

Cue Biopharma all-time high quarterly cash flow from operations is -$1.85 M

What is Cue Biopharma quarterly CFO year-on-year change?

Over the past year, CUE quarterly cash flow from operations has changed by +$2.46 M (+24.65%)

What is Cue Biopharma TTM cash flow from operations?

The current TTM CFO of CUE is -$38.26 M

What is the all time high TTM CFO for Cue Biopharma?

Cue Biopharma all-time high TTM cash flow from operations is -$3.46 M

What is Cue Biopharma TTM CFO year-on-year change?

Over the past year, CUE TTM cash flow from operations has changed by +$272.00 K (+0.71%)